Integral Health Asset Management, LLC Amarin Corp Plcuk Transaction History

Integral Health Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$2.85 - $3.73 $570,000 - $746,000	-200,000 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$3.24 - $5.18 $648,000 - $1.04 Million	200,000 New	200,000 $674,000
Q2 2021 Aug 13, 2021	SELL	$4.26 - $6.5 $2.13 Million - $3.25 Million	-500,000 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$5.03 - $8.8 $2.52 Million - $4.4 Million	500,000 New	500,000 $3.11 Million
Q3 2020 Nov 16, 2020	SELL	$3.64 - $7.76 $1.27 Million - $2.72 Million	-350,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$4.78 - $8.26 $1.67 Million - $2.89 Million	350,000 New	350,000 $2.42 Million
Q1 2020 May 15, 2020	SELL	$4.0 - $21.53 $700,000 - $3.77 Million	-175,000 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$13.94 - $24.12 $2.44 Million - $4.22 Million	175,000 New	175,000 $3.75 Million

102

59.6M

133K

26.4K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $6.04B
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.